Encyclopedia of Experiments: Immunology
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Transcript
Following vascular injury, platelets are recruited and activated at the injury site to form a platelet plug and initiate tissue repair.
To purify platelets from murine whole blood and activate them in vitro, take a suitable density gradient medium. Carefully layer the blood sample on top of the medium. Centrifuge to separate the platelets from the plasma and the red and white blood cell layers.
Transfer the platelets to two new tubes containing a suitable staining buffer. Add the synthetic GPRP tetrapeptide containing the glycine-proline-arginine-proline amino acid sequence to one tube, followed by thrombin.
Thrombin cleaves specific extracellular domains of the platelet-surface thrombin receptors, initiating a downstream signaling cascade and activating the platelets. The activated platelets' granules release CD62P protein, which rapidly translocates to the membrane surface.
The GPRP tetrapeptide blocks fibrinogen — a glycoprotein that binds to the membrane-spanning integrin CD41/CD61 on activated platelets to initiate platelet aggregation — thereby maintaining the activated platelets in suspension.
Add fluorescently-labeled anti-CD41 and anti-CD62P antibodies to the platelet-containing tubes.
The anti-CD41 antibodies bind to the CD41 ubiquitously expressed on resting and activated platelets. However, anti-CD62P specifically binds to the CD62P translocated to the membrane surface of activated platelets.
Analyze the cells using flow cytometry. Resting platelets appear as CD41+ cells, whereas activated platelets are characterized as CD41+ CD62P+ cells.
